AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based group (capitated fee for all services)
Number of subjects: 0
Study 7748586 — intervention group
Group type: COMPARATOR
Intervention: Physician-based group (fee-for-service for each service)
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition program eligibility
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation program eligibility
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol counseling program eligibility
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia/depression evaluations eligibility
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: General use of preventive services
Number of subjects: 0
Study 7748586 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouragement by doctors
Number of subjects: 0
Study 2263931 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 20
Study 2263931 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 20
Study 6449095 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 20
Study 6449095 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 1000
Number of subjects: 20
Study 6449095 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 30616086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer registrations at one‐year post‐diagnosis
Number of subjects: 641
Study 30616086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer registrations at six‐years post‐diagnosis
Number of subjects: 641
Study 30616086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer registrations (one‐year post‐diagnosis) & hospital episode statistics combined
Number of subjects: 641
Study 27503249 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine curcumin extract
Number of subjects: 0
Study 27503249 — intervention group
Group type: COMPARATOR
Intervention: Standard curcumin extract
Number of subjects: 0
Study 25569524 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (decompressive laminectomy)
Number of subjects: 0
Study 25569524 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 0
Study 23770890 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate cycling exercise
Number of subjects: 11
Study 23770890 — intervention group
Group type: COMPARATOR
Intervention: Common relaxation
Number of subjects: 11
Study 21087294 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate non-occlusal loading (restored with a non-occluding temporary crown within 24 hours after implant placement)
Number of subjects: 62
Study 21087294 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading (restored according to a two-stage procedure after 3 months)
Number of subjects: 62
Study 18608144 — intervention group
Group type: EXPERIMENTAL
Intervention: AAC device primed with task specific vocabularies
Number of subjects: 0
Study 18608144 — intervention group
Group type: COMPARATOR
Intervention: AAC device not primed with task specific vocabularies
Number of subjects: 0
Study 18608144 — intervention group
Group type: EXPERIMENTAL
Intervention: Two different emulations of human performance
Number of subjects: 0
Study 17961903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system (SA primer and Photo Bond) under water contamination
Number of subjects: 128
Study 17961903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) without adhesive system under water contamination
Number of subjects: 128
Study 17961903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system under saliva contamination
Number of subjects: 128
Study 17961903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant (Teethmate F) with adhesive system under dry conditions
Number of subjects: 128
Study 17961903 — intervention group
Group type: COMPARATOR
Intervention: Fissure sealant (Teethmate F) under dry conditions
Number of subjects: 128
Study 15151953 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy followed by surgery (CRT-S)
Number of subjects: 101
Study 15151953 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 101
Study 12164890 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation during hemodialysis
Number of subjects: 85
Study 9854466 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptamine (serotonin) infusion at increasing doses (15 nmol.min-1.kg-1 and 60 nmol.min-1.kg-1)
Number of subjects: 0
Study 9854466 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study 7824143 — intervention group
Group type: EXPERIMENTAL
Intervention: IQCODE
Number of subjects: 460
Study 2096043 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemicolectomy
Number of subjects: 260
Study 2096043 — intervention group
Group type: COMPARATOR
Intervention: Segmental colectomy
Number of subjects: 260
Study 406103 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone valerate
Number of subjects: 22
Study 406103 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 22
Study 406103 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (betamethasone valerate and sodium cromoglycate)
Number of subjects: 22
Study 31209607 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-gauge FNB needle
Number of subjects: 88
Study 31209607 — intervention group
Group type: COMPARATOR
Intervention: 25-gauge FNB needle
Number of subjects: 88
Study 31209607 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 30202856 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Trimodal Imaging (ETMI)
Number of subjects: 210
Study 30202856 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE)
Number of subjects: 210
Study 26479132 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily monitoring condition (n = 89)
Number of subjects: 176
Study 26479132 — intervention group
Group type: COMPARATOR
Intervention: No monitoring condition (n = 87)
Number of subjects: 176
Study 26479132 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily report total cigarettes
Number of subjects: 176
Study 26479132 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair nicotine (NIC), hair cotinine (COT), and expired-air carbon monoxide (CO)
Number of subjects: 176
Study 24731062 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets (SLB; F1000, Leone S.p.A.)
Number of subjects: 40
Study 24731062 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets (CB; Avex Mx, OPAL orth.)
Number of subjects: 40
Study 22531569 — intervention group
Group type: EXPERIMENTAL
Intervention: True TENS on acupoints (bilateral P6, L14; ST36, GB31 ipsilateral to the surgery site)
Number of subjects: 68
Study 22531569 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 68
Study 20350035 — intervention group
Group type: EXPERIMENTAL
Intervention: High school risk behaviors leading to increased first-semester college risk behaviors (sexual partners, hookups, heavy episodic drinking, heavy drinking contexts)
Number of subjects: 469
Study 20350035 — intervention group
Group type: EXPERIMENTAL
Intervention: College risk behaviors (higher levels of risk taking)
Number of subjects: 469
Study 17682112 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/d
Number of subjects: 937
Study 17682112 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/d
Number of subjects: 937
Study 17682112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 937
Study 15727691 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosage (120 mg/d) of diisopropylamine dichloroacetate
Number of subjects: 123
Study 15727691 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dosage (60 mg/d) of diisopropylamine dichloroacetate
Number of subjects: 123
Study 12085068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair Apposition Technique (HAT)
Number of subjects: 189
Study 12085068 — intervention group
Group type: COMPARATOR
Intervention: Standard Suturing
Number of subjects: 189
Study 9466512 — intervention group
Group type: EXPERIMENTAL
Intervention: Candid 1, a live attenuated Junin virus vaccine
Number of subjects: 6500
Study 9466512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6500
Study 7614525 — intervention group
Group type: EXPERIMENTAL
Intervention: TAA Aqueous 220 micrograms/d
Number of subjects: 429
Study 7614525 — intervention group
Group type: EXPERIMENTAL
Intervention: TAA Aqueous 110 micrograms/d
Number of subjects: 429
Study 7614525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study 1974685 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0
Study 1974685 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 0
Study 365797 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid (CDCA), 200 mg/day for 5 days
Number of subjects: 0
Study 365797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31991529 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic stressors (physical, economic, and interpersonal stressor; physical and economic stressor; interpersonal stressor; physical stressor; low stressor)
Number of subjects: 304
Study 31991529 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping strategies (cognitive coping, support-seeking, positive problem solving, escape-avoidance)
Number of subjects: 304
Study 31670004 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telemonitored PAP treatment (TG)
Number of subjects: 70
Study 31670004 — intervention group
Group type: COMPARATOR
Intervention: Standard PAP treatment (SG)
Number of subjects: 70
Study 28480505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardamom supplementation (3 g d-1) for 8 weeks
Number of subjects: 80
Study 28480505 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical inert) for 8 weeks
Number of subjects: 80
Study 26423928 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 2278
Study 26423928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2278
Study 26423928 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (DA and placebo)
Number of subjects: 2278
Study 22835761 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-inducing antiepileptic drugs (EI-AEDs)
Number of subjects: 35
Study 21189395 — intervention group
Group type: EXPERIMENTAL
Intervention: AC plus trastuzumab (doxorubicin and cyclophosphamide with trastuzumab)
Number of subjects: 4943
Study 21189395 — intervention group
Group type: COMPARATOR
Intervention: AC alone (doxorubicin and cyclophosphamide)
Number of subjects: 4943
Study 21189395 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 4943
Study 21189395 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline-containing chemotherapy
Number of subjects: 4943
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modifications (dietary sodium restriction, aerobic exercise, weight management, alcohol limitation, diet rich in fruits and vegetables, stress management)
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological management (thiazide diuretics, ACE inhibitors, CCBs, ARBs, beta-blockers)
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (two first-line agents)
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors or ARBs for patients with diabetes mellitus
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors for patients with proteinuric nondiabetic chronic kidney disease
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy for selected high-risk patients with hypertension
Number of subjects: 0
Study 18548143 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid therapy
Number of subjects: 0
Study 16781245 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute SHORT cycle bout (LITE)
Number of subjects: 45
Study 16781245 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute LONG cycle bout (LITE)
Number of subjects: 45
Study 16781245 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute SHORT cycle bout (MOD)
Number of subjects: 45
Study 16781245 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute LONG cycle bout (MOD)
Number of subjects: 45
Study 14505290 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary calcium screening with electron beam tomography
Number of subjects: 0
Study 14505290 — intervention group
Group type: COMPARATOR
Intervention: Routine evaluation using Framingham risk assessment
Number of subjects: 0
Study 10860407 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive context
Number of subjects: 0
Study 10860407 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral context
Number of subjects: 0
Study 10860407 — intervention group
Group type: EXPERIMENTAL
Intervention: Provoking context
Number of subjects: 0
Study 10860407 — intervention group
Group type: EXPERIMENTAL
Intervention: Hostility
Number of subjects: 0
Study 10860407 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived social support
Number of subjects: 0
Study 9127392 — intervention group
Group type: EXPERIMENTAL
Intervention: SVC lead position at the brachiocephalic vein
Number of subjects: 24
Study 9127392 — intervention group
Group type: EXPERIMENTAL
Intervention: SVC lead position at mid-RA
Number of subjects: 24
Study 9127392 — intervention group
Group type: EXPERIMENTAL
Intervention: SVC lead position at RA-SVC junction
Number of subjects: 24
Study 9127392 — intervention group
Group type: EXPERIMENTAL
Intervention: Best SVC lead position identified in 83% of patients
Number of subjects: 24
Study 9127392 — intervention group
Group type: EXPERIMENTAL
Intervention: Best SVC lead position
Number of subjects: 24
Study 7941489 — intervention group
Group type: EXPERIMENTAL
Intervention: Board game intervention as a primary prevention teaching strategy
Number of subjects: 23
Study 3236957 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week extension and a long period of non-weight bearing
Number of subjects: 40
Study 3236957 — intervention group
Group type: COMPARATOR
Intervention: Early mobilisation and partial weight bearing up to the 11th week
Number of subjects: 40
Study 31916660 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 194
Study 31916660 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 194
Study 31916660 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prolonged exposure and sertraline
Number of subjects: 194
Study 31916660 — intervention group
Group type: COMPARATOR
Intervention: No CG
Number of subjects: 194
Study 31916660 — intervention group
Group type: EXPERIMENTAL
Intervention: CG group
Number of subjects: 194
Study 30630784 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic impregnated beads
Number of subjects: 72
Study 30630784 — intervention group
Group type: COMPARATOR
Intervention: Closed lavage plus drainage
Number of subjects: 72
Study 25509730 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal vesiculation combined with quick cupping at Shenque (CV 8)
Number of subjects: 82
Study 25509730 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of loratadine and nasal spray of budesonide
Number of subjects: 82
Study 22157521 — intervention group
Group type: EXPERIMENTAL
Intervention: T-wave alternans (TWA) measured in lead V(5)
Number of subjects: 44
Study 22157521 — intervention group
Group type: EXPERIMENTAL
Intervention: R-wave heterogeneity (RWH)
Number of subjects: 44
Study 22157521 — intervention group
Group type: EXPERIMENTAL
Intervention: T-wave heterogeneity (TWH)
Number of subjects: 44
Study 22157521 — intervention group
Group type: COMPARATOR
Intervention: Matched patients without VT
Number of subjects: 44
Study 21105792 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein and low-glycemic-index diet
Number of subjects: 773
Study 21105792 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein and high-glycemic-index diet
Number of subjects: 773
Study 21105792 — intervention group
Group type: COMPARATOR
Intervention: Low-protein-high-glycemic-index diet
Number of subjects: 773
Study 21105792 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 773
Study 21105792 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic-index diet
Number of subjects: 773
Study 17965119 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 1105
Study 17965119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1105
Study 16115245 — intervention group
Group type: EXPERIMENTAL
Intervention: Dreaming during anaesthesia
Number of subjects: 864
Study 12867608 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based adjuvant chemotherapy
Number of subjects: 570
Study 12867608 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 570
Study 10896013 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-month low-intensity supervised exercise (n = 48)
Number of subjects: 84
Study 10896013 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised home-based flexibility activities (n = 36)
Number of subjects: 84
Study 8736270 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy (2.0 IU/m2 per day)
Number of subjects: 29
Study 8736270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 1704985 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 11
Study 1704985 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 11
Study 1704985 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nitrendipine and cilazapril
Number of subjects: 11
Study 1704985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 6986758 — intervention group
Group type: COMPARATOR
Intervention: 1000 kcal extra glucose per day
Number of subjects: 15
Study 6986758 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 kcal extra fructose per day
Number of subjects: 15
Study 31638838 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain cereal (WGC)
Number of subjects: 0
Study 31638838 — intervention group
Group type: COMPARATOR
Intervention: Refined cereal (RC)
Number of subjects: 0
Study 30701292 — intervention group
Group type: EXPERIMENTAL
Intervention: Local radiotherapy (RT) to the primary tumor and pelvic lymphatics in 44 patients (41%)
Number of subjects: 106
Study 30701292 — intervention group
Group type: COMPARATOR
Intervention: No local RT to the primary tumor in 62 patients (59%)
Number of subjects: 106
Study 30701292 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary RT to the prostate
Number of subjects: 106
Study 30701292 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA response ≥50% of baseline obtained 3 weeks after abiraterone therapy
Number of subjects: 106
Study 26156116 — intervention group
Group type: EXPERIMENTAL
Intervention: Solar-powered oxygen delivery systems
Number of subjects: 0
Study 26156116 — intervention group
Group type: COMPARATOR
Intervention: Oxygen from cylinders
Number of subjects: 0
Study 23953493 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (≥100 mg/day)
Number of subjects: 151
Study 23953493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 23953493 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 151
Study 23953493 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 151
Study 21421726 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-773812 56 mg
Number of subjects: 30
Study 21421726 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-773812 100 mg/d
Number of subjects: 30
Study 21421726 — intervention group
Group type: COMPARATOR
Intervention: risperidone 6 mg/d
Number of subjects: 30
Study 19214342 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-8 g oat-bran/d for 12 weeks (fiber group)
Number of subjects: 30
Study 19214342 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oat-bran)
Number of subjects: 30
Study 17287150 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 17287150 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-BP Monitoring (SBPM)
Number of subjects: 0
Study 17287150 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-BP Monitoring plus telephone-based nurse case management (SBPM+NCM)
Number of subjects: 0
Study 15534128 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% pirenzepine ophthalmic gel
Number of subjects: 174
Study 15534128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 11762417 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody therapy
Number of subjects: 0
Study 9377657 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin and immunoglobulin levels in cerebrospinal fluid and serum
Number of subjects: 14
Study 9377657 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF/serum albumin ratio
Number of subjects: 14
Study 9377657 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of albumin and immunoglobulins
Number of subjects: 14
Study 8055291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconvulsive electrical stimulation during ECT sessions
Number of subjects: 0
Study 8055291 — intervention group
Group type: COMPARATOR
Intervention: Convulsive stimulation during ECT sessions
Number of subjects: 0
Study 2970853 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (ISRP) 12 mg/day
Number of subjects: 98
Study 2970853 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 60 mg/day
Number of subjects: 98
Study 2970853 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (ISRP)
Number of subjects: 98
Study 2970853 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 98